XML 16 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Director
Common Stock
Common Stock
Director
Additional Paid-in Capital
Additional Paid-in Capital
Director
Accumulated Deficit
Treasury Stock
Beginning balance, shares outstanding at Dec. 31, 2024     15,254          
Beginning balance at Dec. 31, 2024 $ 208,550   $ 269   $ 243,825   $ 243,209 $ (278,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 32,665           32,665  
Issuance of common stock from employee stock purchase plan (in shares)     20          
Issuance of common stock from employee stock purchase plan 662       662      
Issuance of common stock to directors and board advisor (in shares)     3          
Issuance of common stock to directors and board advisor 140       140      
Issuance of common stock to former executive (in shares)     271          
Issuance of common stock to former executive 0   $ 3   (3)      
Issuance of restricted common stock (in shares)     115          
Issuance of restricted common stock 0   $ 1   (1)      
Exercise of stock options (in shares)     79          
Exercise of stock options 321       321      
Restricted common stock, performance awards, and stock options surrendered for taxes paid (in shares)     (53)          
Restricted common stock, performance awards, and stock options surrendered for taxes paid (7,631)       (7,631)      
Stock-based compensation expense 3,705       3,705      
Dividends on common stock (3,488)       (3,488)      
Other (in shares)     12          
Other 496       496      
Ending balance, shares outstanding at Jun. 30, 2025     15,701          
Ending balance at Jun. 30, 2025 235,420   $ 273   238,026   275,874 (278,753)
Beginning balance, shares outstanding at Mar. 31, 2025     15,693          
Beginning balance at Mar. 31, 2025 223,062   $ 273   237,407   264,135 (278,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 11,739           11,739  
Issuance of common stock from employee stock purchase plan (in shares)     9          
Issuance of common stock from employee stock purchase plan 295       295      
Issuance of common stock to former executive (in shares)       1        
Issuance of common stock to former executive   $ 63       $ 63    
Exercise of stock options (in shares)     2          
Exercise of stock options 0       0      
Restricted common stock, performance awards, and stock options surrendered for taxes paid (in shares)     (4)          
Restricted common stock, performance awards, and stock options surrendered for taxes paid (2)       (2)      
Stock-based compensation expense 2,029       2,029      
Dividends on common stock (1,766)       (1,766)      
Ending balance, shares outstanding at Jun. 30, 2025     15,701          
Ending balance at Jun. 30, 2025 235,420   $ 273   238,026   275,874 (278,753)
Beginning balance, shares outstanding at Dec. 31, 2025     15,751          
Beginning balance at Dec. 31, 2025 254,776   $ 274   238,539   294,716 (278,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 25,764           25,764  
Issuance of common stock from employee stock purchase plan (in shares)     18          
Issuance of common stock from employee stock purchase plan 685       685      
Issuance of common stock to directors and board advisor (in shares)     3          
Issuance of common stock to directors and board advisor 125       125      
Issuance of restricted common stock (in shares)     110          
Issuance of restricted common stock 0   $ 1   (1)      
Exercise of stock options (in shares)     63          
Exercise of stock options 3       3      
Restricted common stock, performance awards, and stock options surrendered for taxes paid (in shares)     (62)          
Restricted common stock, performance awards, and stock options surrendered for taxes paid (2,387)       (2,387)      
Stock-based compensation expense 3,901       3,901      
Dividends on common stock (3,557)       (3,557)      
Other (in shares)     1          
Other 59       59      
Ending balance, shares outstanding at Jun. 30, 2026     15,884          
Ending balance at Jun. 30, 2026 279,369   $ 275   237,367   320,480 (278,753)
Beginning balance, shares outstanding at Mar. 31, 2026     15,872          
Beginning balance at Mar. 31, 2026 266,939   $ 275   237,209   308,208 (278,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 12,272           12,272  
Issuance of common stock from employee stock purchase plan (in shares)     8          
Issuance of common stock from employee stock purchase plan 325       325      
Issuance of common stock to former executive (in shares)       2        
Issuance of common stock to former executive   $ 62       $ 62    
Exercise of stock options (in shares)     18          
Exercise of stock options 3       3      
Restricted common stock, performance awards, and stock options surrendered for taxes paid (in shares)     (16)          
Restricted common stock, performance awards, and stock options surrendered for taxes paid (315)       (315)      
Stock-based compensation expense 1,868       1,868      
Dividends on common stock (1,785)       (1,785)      
Ending balance, shares outstanding at Jun. 30, 2026     15,884          
Ending balance at Jun. 30, 2026 $ 279,369   $ 275   $ 237,367   $ 320,480 $ (278,753)